DFINE Receives CE Mark for STAR Tumor Ablation System

DFINE, a spine device company, has received the CE Mark approval for the STAR Tumor Ablation System for treating painful metastatic spinal tumors.

Advertisement

The company plans to launch the STAR System in Europe next week. The system received the FDA 510(k) clearance in 2010. The system was developed for physicians to target where the device’s energy is delivered to heat and destroy the tumor.

 

More Articles on Spine Devices:
Invibio Biomaterial Solutions Launches Enhanced PEEK-OPTIMA HA Polymer
Titan Spine Debuts Study Supporting Device Surface Technology
SI-BONE Reaches 25k Implantation Milestone for iFuse Device

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.